The Public Readiness and Emergency Preparedness Act (PREPA), passed by the United States Congress and signed into law by President of the United States George W. Bush in December 2005 (as part of Pub. L. 109–148 (text) (PDF) ), is a controversial tort liability shield intended to protect pharmaceutical manufacturers from financial risk in the event of a declared public health emergency. The part of PREPA that actually affords such protection is now codified at 42 U.S.C. § 247d-6d . The act specifically affords to drug makers immunity from actions related to the manufacture, testing, development, distribution, administration and use of medical countermeasures against chemical, biological, radiological and nuclear agents of terrorism, epidemics, and pandemics. PREPA strengthens and consolidates the oversight of litigation against pharmaceutical companies under the purview of the secretary of Health and Human Services (HHS). PREPA provides $ 3.8 billion for pandemic influenza preparedness to protect public health in the case of a pandemic disease outbreak.
44-611: PREPA or prepa may refer to: the Public Readiness and Emergency Preparedness Act the Puerto Rico Electric Power Authority Classe préparatoire aux grandes écoles , part of the French educational system See also [ edit ] Prepa Topics referred to by the same term [REDACTED] This disambiguation page lists articles associated with
88-583: A Department of Defense - appropriations bill ( H.R. 2863 ) while the bill was negotiated between the Senate and the House of Representatives. On December 19, 2005, the appropriations bill with the PREPA legislation was approved by the House of Representatives in a vote of 308–106 , with 2 voting Present and 18 not voting. On December 22, it was approved by the Senate in a vote of 93–0 , with 7 not voting. President Bush signed
132-521: A covered person" that constitute willful misconduct. A plaintiff whose claim is subject to PREPA can sue the defendant only in the United States District Court for the District of Columbia . For such a civil action, PREPA requires the complaint to be pleaded with particularity, verified under oath by the plaintiff, and accompanied by an affidavit from a non-treating physician to explain how
176-533: A giveaway to the drug industry. Kennedy said the bill makes it "essentially impossible" for injured parties to sue for damages, and that the measure allows common diseases to be used as a reason to activate the liability shield. Kennedy also asserted that one of the drug companies that lobbied for PREPA is Sanofi Pasteur, which was under Food and Drug Administration (FDA) investigation for being connected to at least five cases of Guillain–Barré syndrome asserted to have been caused by its meningococcal vaccine. When
220-562: A legal process to compensate certain forms of vaccination injuries; the program was set up by statute in 1985, and its first awards were made in 1988. On 10 December 2020, the nations was made aware via an op-ed published in the Globe and Mail that "Canada needs to prepare for rare but serious health problems resulting from [Covid-19] vaccination" by, inter alia, the Honourable Dr Jane Philpott , former cabinet member and Dean of
264-410: A medical condition of increasing prevalence or unknown cause is due to an adverse effect of vaccination. The initial study, and subsequent studies by the same investigators, have inadequate methodology, typically a poorly controlled or uncontrolled case series. A premature announcement is made of the alleged adverse effect, which resonates with individuals who have the condition and which underestimates
308-446: A prudent manufacturer to exercise caution. Pursuant to such an emergency declaration, liability protection would extend to doctors and other individuals and organizations involved with countermeasures, which may include any medical product to prevent, treat, mitigate, or diagnose an epidemic . The act does not list any criteria for determining the existence of an emergency, but it does specify that any such declaration would have to list
352-412: A series of full page advertisements in various publications in opposition to PREPA. Because the legislation delegates broad legislative power to the executive branch of government, opponents view it as a violation of fundamental principles of the U.S. Constitution . In 2005, Senator Edward Kennedy issued a statement demanding repeal of the PREPA legislation, while condemning the liability provisions as
396-553: A severe allergic reaction. Allegations particularly focus on disorders claimed to be caused by the MMR vaccine and thiomersal , a preservative used in vaccines routinely given to U.S. infants prior to 2001. Current scientific evidence does not support claims of vaccines causing various disorders. The debate is complicated by misconceptions around the recording and reporting of adverse events by anti-vaccination activists. According to authorities, anti-vaccination websites greatly exaggerate
440-486: A streamlined system for litigating vaccine injury claims under which the claimant must show that the vaccine caused the injury, but just as in litigation for injury by any other product, they are not required to establish it was anyone's fault (i.e. negligence need not be proven) Claims that are denied can be pursued through civil lawsuits, though this is rare, and the statute creating the VICP also imposes substantial limitations on
484-406: A variety of lawsuits, many involving skilled nursing or assisted living facilities where COVID-19 countermeasures including the administration or non-administration of vaccines is said to have resulted in or contributed to resident deaths. Although PREPA was around for more than 15 years, prior to COVID-19, the act's defensive application in litigation was not widespread, but now the application of
SECTION 10
#1732884311320528-696: Is a subculture of advocates who attribute their children's autism to vaccine injury, despite the fact that vaccines do not cause autism. Claims of vaccine injuries appeared in litigation in the United States in the latter part of the 20th century. Some families have won substantial awards from sympathetic juries, even though many public health officials have said that the claims of injuries are unfounded. In response, several vaccine makers stopped production, threatening public health , resulting in laws being passed at several points to shield makers from liabilities stemming from vaccine injury claims. According to
572-456: Is currently £120,000. The 'disability threshold' before payments are granted is 60%. The scheme covers vaccinations for illnesses such as tetanus , measles , tuberculosis , and meningitis C. As of 2005, the British government had paid out £3.5 million to vaccine injury patients since 1997. Until the advent of COVID-19 , disabled vaccine injury patients were allowed to file a claim up to
616-421: Is taken very seriously by the scientific community, with constant monitoring of a number of data sources looking for patterns of adverse events. As the success of immunization programs increases and the incidence of disease decreases, public attention shifts away from the risks of disease to the risk of vaccination. Concerns about immunization safety often follow a pattern. First, some investigators suggest that
660-548: The Federal Food, Drug, and Cosmetic Act of 1938, specifically section 201(g) drugs and section 201(h) medical devices . The definitions of security countermeasure and biological product are related only internally. PREPA covers many kinds of loss, including Numerous consumer organizations vigorously opposed the legislation, including A-CHAMP , Eagle Forum , and Public Citizen , as well as first responder organizations representing nurses, firemen and veterans. A-CHAMP ran
704-529: The Food and Drug Administration (FDA) and the Centers for Disease Control and Prevention (CDC). VAERS is intended to track adverse events associated with vaccines. VAERS collects and analyzes information from reports of adverse events that occur after the administration of US licensed vaccines. VAERS has several limitations, including underreporting, unverified reports, inconsistent data quality, and inadequate data about
748-534: The Faculty of Health Sciences of Queen's University . The authors observed that, outside of Quebec, "People suffering severe AEFIs are left to assume the costs of legal fees, lost wages, uninsured medical services and rehabilitation supports", and plumped for a no-fault system , in which "compensation is needs-based and not punitive." They go on to write: In the context of the COVID-19 pandemic, we are concerned that, given
792-462: The PREPA legislation was presented, its broad liability shields, its potential for undermining state vaccine laws, and its consolidation of responsibility within the executive branch were misrepresented in Congress and media, according to critics, who note that it was portrayed instead as primarily concerned with preparations to combat the avian flu. Opponents also contended that PREPA would contribute to
836-405: The U.S. Centers for Disease Control and Prevention , while "any vaccine can cause side effects", most side effects are minor, primarily including sore arms or a mild fever. Unlike most medical interventions vaccines are given to healthy people, where the risk of side effects is not as easily outweighed by the benefit of treating existing disease. As such, the safety of immunization interventions
880-594: The United Kingdom include vaccines under their general requirements for reporting injuries associated with medical treatments. A number of countries have programs for the compensation of injuries alleged to have been caused by a vaccination. In 1988, the National Vaccine Injury Compensation Program (VICP) went into effect to compensate individuals and families of individuals who have been injured by specified childhood vaccines. The VICP
924-471: The VICP. 2,620 of these claims, one autism-related, were compensated, with 4,463 non-autism and 814 autism claims dismissed; awards (including attorney's fees) totaled over $ 2 billion. The VICP also applies to claims for injuries sustained before 1988; there were 4,264 of these claims of which 1,189 were compensated with awards totaling $ 903 million. As of October 2019, $ 4.2 billion in compensation (not including attorneys fees and costs) has been awarded over
SECTION 20
#1732884311320968-574: The ability to pursue such lawsuits. The VICP covers all vaccines listed on the Vaccine Injury Table which is maintained by the Secretary of Health and Human Services. To win an award, a claimant is required to show a causal connection between an injury and one of the vaccines listed in the Vaccine Injury Table. Compensation is payable for "table" injuries, those listed in the Vaccine Injury Table, as well as, "non-table" injuries, injuries not listed in
1012-411: The act is being included more frequently in a variety of COVID-19 related lawsuits, including Shareholder Derivative Litigation . Legislative leaders Senator Bill Frist and Congressman Dennis Hastert were among the backers of PREPA legislation. Rep. Nathan Deal spoke on the House floor in support of the bill, calling it "absolutely critical legislation". It was added to the final version of
1056-428: The age of 21. On the 2 December 2020, government agreed under regulation secondary to the 1979 Act the statutory £120,000 blanket payout for any person provably damaged by the vaccine, and by the same addition of COVID-19 to the list, government-approved Covax manufacturers were exempted from legal pursuit. Individuals who provide the vaccine (and thus are permitted by government to do so) are also protected. Quebec has
1100-523: The anticipated scale of the COVID-19 immunization campaign and new vaccine technologies employed, mass immunization may result in a small number of Canadians experiencing serious AEFIs, despite adherence to best practices. While AEFIs are possible with routine immunizations, pandemic situations are unique with respect to the speed and scale with which vaccine technologies are developed and distributed. Rare serious AEFIs may not be captured during phases of clinical trials because it may require very large numbers of
1144-539: The bill into law on December 30. Of the $ 3.8 billion earmarked for pandemic preparedness, $ 350 million is slated for improvement of state and local preparedness. HHS will use most of the balance on "core preparedness activities", such as developing vaccines and stockpiling antiviral drugs. Under PREPA, an HHS emergency declaration will trigger establishment of a fund for "timely, uniform, and adequate compensation" program for vaccine injuries , but no funding provisions for such purposes were included in its language. PREPA
1188-446: The case of pandemic, epidemic, or other major security threat requiring a medical countermeasures , such as vaccines and medications, the CICP provides compensation to eligible individuals for serious physical injuries or death. Covid-19 vaccines are covered under the program. The Vaccine Adverse Event Reporting System (VAERS) is a passive surveillance program administered jointly by
1232-455: The covered countermeasure injured the plaintiff, as well as relevant medical records. In the event of an emergency declared by HHS, Federal law would preempt all state provisions related to pandemic emergency preparedness, and would supersede any state provision governing vaccines. PREPA applies to any drug, vaccine, or biological product that the HHS secretary deems a "covered countermeasure," or that
1276-411: The diseases, populations, and geographic areas covered and when the emergency would end. PREPA removes the right to a jury trial for persons injured by a covered vaccine, unless a plaintiff can provide clear evidence of willful misconduct that resulted in death or serious physical injury. The act instructs the HHS secretary to write regulations "that further restrict the scope of actions or omissions by
1320-494: The legislation, which would effectively preempt state vaccine safety laws in the case of an emergency declaration by HHS, by making clear they would not produce new vaccines unless the legislation was enacted. Injured parties are compensated by the Countermeasures Injury Compensation Program . During and in the aftermath of the 2020–21 COVID-19 pandemic in the United States , PREPA is being invoked in
1364-509: The life of the program. As part of NVICP, a table has been created which lists various vaccines, side effects that might plausibly be caused by them, and the time within which the symptoms must present in order to be eligible to apply for compensation. For example, for vaccines containing tetanus toxoid (e.g., DTaP, DTP, DT, Td, or TT), anaphylaxis within four hours or brachial neuritis between two and twenty-eight days after administration, may be compensated. Established by PREP Act , in
PREPA - Misplaced Pages Continue
1408-467: The number of people vaccinated. Due to the program's open and accessible design and its allowance of unverified reports, incomplete VAERS data is often used in false claims regarding vaccine safety. The Vaccine Safety Datalink (VSD), funded by the Centers for Disease Control , is composed of databases from several organizations containing information regarding health outcomes for millions of US citizens and to enhance assessment of vaccine injuries. It
1452-553: The population to be immunized for AEFIs to manifest. The anticipated incidence of serious AEFIs can be estimated at 1 in one million immunizations... the potential health consequences of adverse events following immunization borne by the few will be for our collective benefit in stopping the deadly spread of the virus. Operating under this estimate, we anticipate 25 Canadians may suffer a serious health outcome following COVID-19 vaccination, or 0.1 per 100,000 doses. The authors conclude that an "equitable and fair compensation system with
1496-473: The potential for abuse of discretion by the George W. Bush Administration , which was generally perceived as friendly to the drug industry. In particular, critics were concerned about the possibility that state laws banning thimerosal containing vaccines (TCVs) may be preempted. If the HHS secretary designates that a vaccine is a covered countermeasure, thimerosal (a mercury containing preservative) can be used in
1540-505: The potential harm of not being vaccinated. The initial study is not reproduced by other investigators. Finally, it takes several years before the public regains confidence in the vaccine. Controversies in this area revolve around the question of whether the risks of adverse events following immunization outweigh the benefits of preventing infectious disease. In rare cases immunizations can cause serious adverse effects, such as gelatin measles-mumps-rubella vaccine (MMR) causing anaphylaxis ,
1584-525: The risk of serious adverse effects from vaccines and falsely describe conditions such as autism and shaken baby syndrome as vaccine injuries, leading to misconceptions about the safety and effectiveness of vaccines. This has had the result of stigmatizing autistic people and the parents who had them immunized. Many countries, including Canada, Germany, Japan, and the United States have specific requirements for reporting vaccine-related adverse effects, while other countries including Australia, France, and
1628-738: The secretary decides is a public health situation that could become an emergency at some point in the future, whether or not there is a specific relationship to a dangerous pandemic or bioterrorism . By invoking provisions of PREPA, the HHS secretary can wield broad authority to declare an emergency, which in turn would trigger drug company immunity from liability at any time, thereby conferring upon drug companies legal immunity for harm caused by their misconduct. The immunity that could be conferred on drug and vaccine manufacturers can be applied regardless of wrongdoing by affected drug companies. The PREPA defines terms such as covered countermeasure and qualified pandemic or epidemic product in terms related to
1672-405: The table. In addition, an award may only be given if the claimant's injury lasted for more than 6 months after the vaccine was given, resulted in a hospital stay and surgery or resulted in death. Awards are based on medical expenses, lost earnings and pain and suffering (capped at $ 250,000). From 1988 until March 3, 2011, 5,636 claims relating to autism, and 8,119 non-autism claims, were made to
1716-511: The title PREPA . If an internal link led you here, you may wish to change the link to point directly to the intended article. Retrieved from " https://en.wikipedia.org/w/index.php?title=PREPA&oldid=933064028 " Category : Disambiguation pages Hidden categories: Short description is different from Wikidata All article disambiguation pages All disambiguation pages Public Readiness and Emergency Preparedness Act Vaccine manufacturers lobbied for
1760-494: The vaccination process (administration error or stress related reactions) or can occur independently from vaccination (coincidental). Most vaccine adverse events are mild. Serious injuries and deaths caused by vaccines are very rare, and the idea that severe events are common has been classed as a "common misconception about immunization" by the WHO. Some claimed vaccine injuries are not, in fact, caused by vaccines; for example, there
1804-410: The vaccine, even in states that have enacted such bans. Vaccine injury A vaccine adverse event (VAE), sometimes referred to as a vaccine injury , is an adverse event believed to have been caused by vaccination . The World Health Organization (WHO) refers to Adverse Events Following Immunization ( AEFI ). AEFIs can be related to the vaccine itself (product or quality defects), to
PREPA - Misplaced Pages Continue
1848-469: Was adopted in response to an earlier scare over the pertussis portion of the DPT vaccine. These claims were later generally discredited, but some U.S. lawsuits against vaccine makers won substantial awards; most makers ceased production, and the last remaining major manufacturer threatened to do so. As of October 2019, $ 4.2 billion in compensation (not including attorneys fees and costs) has been awarded. VICP uses
1892-589: Was designed specifically to encourage rapid production of vaccines to protect American citizens in case of a potential public health threat. However, the primary effects of the legislation hinge on liability protections for drug companies, under provisions intended to remove financial risk barriers for any new vaccines that need to be rushed to market in case of an emergency. Under PREPA, the HHS secretary will have primary responsibility for making decisions on whether or not to declare an emergency that would justify removing financial risk barriers, which otherwise would cause
1936-579: Was designed to allow for such things as comparisons between vaccinated and non-vaccinated populations, and for the identification of possible groups at risk for adverse events. The Vaccine Damage Payment Act 1979 governs AEFIs in the UK, and sets up the Vaccine Damage Payment Scheme (VDPS). Under the VDPS, it is thought that thousands of unsuccessful claims have been made. The maximum payment per claim
#319680